Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 3/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.34 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | NPC1 | O15118 | 3/20 | 0.32 |
| ▸ | RAB9A | P51151 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362227 | 1.00 | NQO2 (0.37) | NQO2CYP19A1HSP90AA1HSP90AB1PTGS2 | |
| SCHEMBL29565955 | 1.00 | NQO2 (0.37) | NQO2CYP19A1HSP90AA1HSP90AB1PTGS2 | |
| Hydrochloric Acid SCHEMBL3108310 | 0.97 | NQO2 (0.35) | NQO2CYP19A1HSP90AA1HSP90AB1PTGS2 | |
| SCHEMBL6213387 | 0.87 | ALDH1A1 (0.33) | ALDH1A1NPC1RAB9AKDM4EMAPT | |
| SCHEMBL697978 | 0.87 | HSP90AA1 (0.39) | NQO2CYP19A1HSP90AA1HSP90AB1PTGS2 | |
| SCHEMBL14356056 | 0.86 | HSP90AA1 (0.37) | NQO2CYP19A1HSP90AA1HSP90AB1ALDH1A1 | |
| SCHEMBL18934246 | 0.86 | — | — | |
| SCHEMBL1144361 | 0.85 | NQO2 (0.33) | NQO2CYP19A1 | |
| SCHEMBL21500141 | 0.85 | — | — | |
| P-Cymene SCHEMBL30477519 | 0.84 | ALDH1A1 (0.34) | HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3710422-B1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-07 | — | — | EP | claimed |
| US-11053188-B2 | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | SYNGENTA PARTICIPATIONS AG (CH) | 2021-07-06 | — | — | US | claimed |
| US-20200407311-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2020-12-31 | — | — | US | claimed |
| CN-111217848-A | Spiro-dihydrobenzothiole diphenol compound, synthesis method and application thereof | 中国科学院上海有机化学研究所 | 2020-06-02 | — | — | CN | claimed |
| CN-111171068-A | Preparation method of silicon spiro-compound | 中国科学院上海有机化学研究所 | 2020-05-19 | — | — | CN | claimed |
| EP-3344605-B1 | METHOD FOR THE PRODUCTION OF PRAZIQUANTEL AND PRECURSORS THEREOF | MERCK PATENT GMBH (DE) | 2020-05-13 | — | — | EP | claimed |
| US-10273213-B2 | Method for the production of praziquantel and precursors thereof | MERCK PATENT GMBH (DE) | 2019-04-30 | — | — | US | claimed |
| US-20180251428-A1 | METHOD FOR THE PRODUCTION OF PRAZIQUANTEL AND PRECURSORS THEREOF | MERCK PATENT GMBH (DE) | 2018-09-06 | — | — | US | claimed |
| EP-3344605-A1 | METHOD FOR THE PRODUCTION OF PRAZIQUANTEL AND PRECURSORS THEREOF | Merck Patent GmbH (DE) | 2018-07-11 | — | — | EP | claimed |
| WO-2017036577-A1 | METHOD FOR THE PRODUCTION OF PRAZIQUANTEL AND PRECURSORS THEREOF | MERCK PATENT GMBH (DE) | 2017-03-09 | — | — | WO | claimed |
| WO-2015178846-A1 | PROCESS FOR THE PREPARATION OF CHIRAL AMINES FROM PROCHIRAL KETONES | SP PROCESS DEVELOPMENT AB (SE) | 2015-11-26 | — | — | WO | claimed |
| WO-2015178847-A1 | PROCESS FOR THE PREPARATION OF CHIRAL AMINES BY ASYMMETRIC HYDROGENATION OF PROCHIRAL OXIMES | SP PROCESS DEVELOPMENT AB (SE) | 2015-11-26 | — | — | WO | claimed |
| EP-2095875-B1 | Homogeneous asymmetric hydrogenation catalyst | TAKASAGO PERFUMERY CO LTD (JP) | 2014-10-01 | — | — | EP | claimed |
| EP-2392400-B1 | Homogeneous asymmetric hydrogenation method | TAKASAGO PERFUMERY CO LTD (JP) | 2014-05-07 | — | — | EP | claimed |
| US-7902110-B2 | Homogeneous asymmetric hydrogenation catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | claimed |
| EP-1650207-B1 | Process for producing optically active 3-quinuclidinols | TAKASAGO PERFUMERY CO LTD (JP) | 2007-06-27 | — | — | EP | claimed |
| US-20260125363-A1 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2026-05-07 | — | — | US | disclosed |
| EP-3792241-B1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | TAKASAGO PERFUMERY CO LTD (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-20020007094-A1 | Method for producing 1-menthol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-01-17 | — | — | US | disclosed |
| EP-1153908-A2 | Method for producing 1-menthol | Takasago International Corporation (JP) | 2001-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125363-A1 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SLC26A4, SLC26A3 | NQO2 1159/4885CYP19A1 4400/4885HSP90AA1 3464/4885 |
| US-10273213-B2 | Method for the production of praziquantel and precursors thereof | CYP51A1, POR, DHPS | NQO2 355/4885CYP19A1 80/4885HSP90AA1 2241/4885 |
| US-20200407311-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | TBCB, ADORA2B, ADRA2B | NQO2 2322/4885CYP19A1 566/4885HSP90AA1 3721/4885 |
| US-20180251428-A1 | METHOD FOR THE PRODUCTION OF PRAZIQUANTEL AND PRECURSORS THEREOF | CYP51A1, POR, DHPS | NQO2 355/4885CYP19A1 80/4885HSP90AA1 2241/4885 |
| US-20020007094-A1 | Method for producing 1-menthol | HRH4, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PHOSPHO1 | NQO2 2093/4885CYP19A1 1798/4885HSP90AA1 1562/4885 |
| US-11053188-B2 | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | TBCB, ADORA2B, CCNB3 | NQO2 2295/4885CYP19A1 494/4885HSP90AA1 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.